HomeCompareDTXMF vs MAIN

DTXMF vs MAIN: Dividend Comparison 2026

DTXMF yields 2099.96% · MAIN yields 7.09%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DTXMF wins by $15665483125.85M in total portfolio value
10 years
DTXMF
DTXMF
● Live price
2099.96%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15665483173.80M
Annual income
$14,323,699,878,768,094.00
Full DTXMF calculator →
MAIN
Main Street Capital Corporation
● Live price
7.09%
Share price
$51.65
Annual div
$3.66
5Y div CAGR
72.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.95M
Annual income
$40,208,699.11
Full MAIN calculator →

Portfolio growth — DTXMF vs MAIN

📍 DTXMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDTXMFMAIN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DTXMF + MAIN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DTXMF pays
MAIN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DTXMF
Annual income on $10K today (after 15% tax)
$178,496.43/yr
After 10yr DRIP, annual income (after tax)
$12,175,144,896,952,880.00/yr
MAIN
Annual income on $10K today (after 15% tax)
$602.32/yr
After 10yr DRIP, annual income (after tax)
$34,177,394.24/yr
At 15% tax rate, DTXMF beats the other by $12,175,144,862,775,486.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DTXMF + MAIN for your $10,000?

DTXMF: 50%MAIN: 50%
100% MAIN50/50100% DTXMF
Portfolio after 10yr
$7832741610.87M
Annual income
$7,161,849,959,488,397.00/yr
Blended yield
91.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MAIN right now

DTXMF
No analyst data
Altman Z
8.7
Piotroski
2/9
MAIN
Analyst Ratings
2
Buy
11
Hold
Consensus: Hold
Price Target
$65.25
+26.3% upside vs current
Range: $60.00 — $70.00
Altman Z
1.7
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DTXMF buys
0
MAIN buys
0
No recent congressional trades found for DTXMF or MAIN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDTXMFMAIN
Forward yield2099.96%7.09%
Annual dividend / share$2.00$3.66
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%72.7%
Portfolio after 10y$15665483173.80M$47.95M
Annual income after 10y$14,323,699,878,768,094.00$40,208,699.11
Total dividends collected$15570599104.15M$46.82M
Payment frequencyquarterlymonthly
SectorStockBDC

Year-by-year: DTXMF vs MAIN ($10,000, DRIP)

YearDTXMF PortfolioDTXMF Income/yrMAIN PortfolioMAIN Income/yrGap
1← crossover$220,696$209,995.80$12,464$1,223.78+$208.2KDTXMF
2$4,567,471$4,331,326.27$16,353$2,343.58+$4.55MDTXMF
3$88,663,041$83,775,847.71$23,105$4,724.42+$88.64MDTXMF
4$1,614,723,560$1,519,854,105.24$36,226$10,256.23+$1614.69MDTXMF
5$27,596,399,156$25,868,644,947.25$65,426$24,707.64+$27596.33MDTXMF
6$442,712,758,641$413,184,611,544.43$142,101$68,562.02+$442712.62MDTXMF
7$6,668,541,041,184$6,194,838,389,437.68$388,521$228,799.95+$6668540.65MDTXMF
8$94,343,071,214,447$87,207,732,300,379.95$1,397,868$961,169.80+$94343069.82MDTXMF
9$1,254,003,079,467,744$1,153,055,993,268,286.20$6,884,663$5,313,459.69+$1254003072.58MDTXMF
10$15,665,483,173,798,580$14,323,699,878,768,094.00$47,947,060$40,208,699.11+$15665483125.85MDTXMF

DTXMF vs MAIN: Complete Analysis 2026

DTXMFStock

Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers esophageal Doppler Probes that is used to measure a patient's central vascular blood flow and fluid status to measure real time blood velocities within the descending aorta; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure waveform analysis algorithm used during periods of instability or for periods when the ODM mode is unavailable. The company also provides Deltex Medical Esophageal Doppler Simulator that enables clinicians to practice probe insertion, focusing, and waveform interpretation outside of a patient setting. Its products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.

Full DTXMF Calculator →

MAINBDC

Main Street Capital Corporation is a business development company specializes in equity capital to lower middle market companies. The firm specializing in recapitalizations, management buyouts, refinancing, family estate planning, management buyouts, refinancing, industry consolidation, mature, later stage emerging growth. The firm also provides debt capital to middle market companies for acquisitions, management buyouts, growth financings, recapitalizations and refinancing. The firm seeks to partner with entrepreneurs, business owners and management teams and generally provides one stop financing alternatives within its lower middle market portfolio. It prefers to invest in air freight and logistics, auto components, building products, chemicals, commercial services, computers, construction and engineering, consumer finance, consumer services, electronic equipment, energy equipment and services, financial services, health care equipment, health care providers, hotels, restaurants, and leisure, internet software and services, IT Services, machinery, oil, gas and consumable fuels, paper and forest products, professional and industrial services, road and rail, software, specialty retail, telecommunication, consumer discretionary, energy, materials, technology, and transportation. The firm typically invests in lower middle market companies generally with annual revenues between $5 million and $300 million. It prefers to invest in ranging between $2 million and $75 million in equity investment and enterprise value in ranging between $3 million and $20 million. The firm typically prefers to invest in the range of $5 million and $50 million per transaction in debt investment value and in the range of $1 million and $20 million in annual EBITDA. The firm's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. It takes 5 percent minority and up to 50 percent majority equity investments. Main Street Capital Corporation was founded in 2007 and is based in Houston, Texas with an additional office in Chojnów, Poland.

Full MAIN Calculator →
📬

Get this DTXMF vs MAIN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DTXMF vs SCHDDTXMF vs JEPIDTXMF vs ODTXMF vs KODTXMF vs ARCCDTXMF vs HTGCDTXMF vs GBDCDTXMF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.